Biomea Fusion share price logo

Biomea Fusion

NASDAQ: BMEA

$1.30

+0.03

(+2.36%)

as on

Biomea Fusion Stock Performance

as on October 6, 2026 at 2:16 pm IST

  • Day's Low

    $1.22
    $1.30
    downward going graph

    6.15%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.87
    $2.99
    downward going graph

    32.93%

    Downside

    130.00%

    Upside

    downward going graph

Biomea Fusion share price movements today

Previous Close
$1.27
Open
$1.26
Volume
1.1M
Market Cap
$91.8M
Day's Low - High
$1.22 - $1.30
52 Week Low - High
$0.87 - $2.99

Biomea Fusion Historical Returns

1 Month Return
-35.96 %
3 Month Return
-5.8 %
1 Year Return
-51.31 %
3 Year Return
-89.72 %
5 Year Return
-89.7 %

Biomea Fusion Stock Fundamentals & Key Indicators

Check Biomea Fusion market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$91.8M

EPS (TTM)

-0.4962

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.56

Industry PE ratio

-3.20

PEG Ratio

-0.01

EBITDA

-34.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-171.19%

Biomea Fusion vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biomea Fusion with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$91.8M-89.70%-2.560.00%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for Biomea Fusion Stock including INR - Dollar returns

The Biomea Fusion stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Biomea Fusion investment value today

Current value as on today

₹52,914

Returns

-₹47,086

(-47.09%)

Returns from Biomea Fusion Stock

-₹51,311 (-51.31%)

Dollar Impact

₹4,225 (+4.23%)

Analyst Recommendation on Biomea Fusion Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Biomea Fusion. Average target price of $6.5

Biomea Fusion Share Price Target

Get share price movements and forecasts by analysts on Biomea Fusion.

What analysts predicted

80%UPSIDE

Target Price

$6.5

Current Price

$1.3

Analyzed by

4 Analysts

High

$7

Target

$6.50

Low

$4

Biomea Fusion target price $6.5, a slight upside of 80% compared to current price of $1.3. According to 4 analysts rating.

Indian Investors' Interest in Biomea Fusion Stock

Search interest for Biomea Fusion Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-68% versus previous 30 day period

Biomea Fusion Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
-
0
0
-
Operating Income
-31
-41
-38
-34
-29
-21
-20
-11
-12
-12
EBITDA
-28
-38
-36
-32
-28
-20
-18
4
-12
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-28
-39
-37
-32
-29
-20
-16
4
-12
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-28
-39
-37
-32
-29
-20
-16
4
-12
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biomea Fusion Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
-
-
-
-
-1
Operating Income
-1
-5
-41
-83
-126
-144
-81
EBITDA
-1
-5
-41
-81
-115
-136
-60
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
0
0
0
1
1
1
Income Before Tax
-1
-5
-41
-81
-117
-138
-61
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-1
-5
-41
-81
-117
-138
-61
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biomea Fusion Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-28
-39
-37
-32
-29
-20
-16
4
-12
-8
Operating Cash Flow
-23
-32
-32
-25
-25
-19
-12
-13
-11
-10
Investing Cash Flow
0
0
0
0
-
-
-
-
0
-
Financing Cash Flow
0
0
1
0
3
39
2
22
-
0
Change in Cash
-23
-31
-31
-25
-22
20
-9
9
-10
-9

Biomea Fusion Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Net Income
-1
-5
-41
-81
-117
-138
-61
Operating Cash Flow
-1
-4
-35
-62
-96
-119
-70
Investing Cash Flow
-
0
-33
27
-2
0
-
Financing Cash Flow
1
65
153
1
163
1
67
Change in Cash
0
61
84
-33
64
-118
-2

Global Institutional Holdings in Biomea Fusion

Check out the Institutions with significant holdings in Biomea Fusion.

Funds
Holdings
Fidelity Mt. Vernon Street Trust
6.12%
Vanguard
3.80%
VANGUARD INDEX FUNDS
3.48%
Dennis J Purcell
2.83%
Michael Rockefeller
1.79%

Biomea Fusion News & Key Events

  • img

    Today's Timeline - 23 September

    Wed, 05:05 PM

    -

    Biomea Fusion terminates proposed public offering due to unfavorable market conditions, with no securities sold.

    Wed, 10:00 PM

    -

    Biomea Fusion completes Phase 1 trial of BMF-500 for acute leukemia, awaiting top-line safety and response data.

Insights on Biomea Fusion

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 689.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 185.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BMEA stock has moved down by -36.0%

About Biomea Fusion

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.
OrganisationBiomea Fusion
Headquarters1599 Industrial Road, San Carlos, CA, 94070, US
IndustryBiotechnology
CEOMichael J. Hitchcock

Key Management of Biomea Fusion

Name

Title

Dr. Stephan Morris M.D.

Chief Development Officer

Mr. Ravi Upasani Ph.D.

Executive Vice President of Intellectual Property

Dr. Michael J. M. Hitchcock Ph.D.

Interim CEO & Director

Mr. Ramses M. Erdtmann

Co-Founder, President, COO & Director

Mr. Heow Tan

Chief Technical & Quality Officer

Caroline Perez- Dupont J.D.

Senior Vice President of Legal

Dr. Thorsten Kirschberg Ph.D.

Executive Vice President of Research

FAQs

What is Biomea Fusion share price today?

Biomea Fusion share price today is $1.30 as on at the close of the market. Biomea Fusion share today touched a day high of $1.30 and a low of $1.22.

What is the 52 week high and 52 week low for Biomea Fusion share?

Biomea Fusion share touched a 52 week high of $2.99 on and a 52 week low of $0.87 on . Biomea Fusion stock price today i.e. is closed at $1.30,which is 56.52% down from its 52 week high and 49.10% up from its 52 week low.

What is Biomea Fusion's market capitalisation today?

Biomea Fusion market capitalisation is $0.00T as on .

How to invest in Biomea Fusion Stock (BMEA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biomea Fusion on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Biomea Fusion Stock (BMEA) from India?

Indian investors can start investing in Biomea Fusion (BMEA) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in Biomea Fusion stock (as per the Rupee-Dollar exchange rate as on ). Based on Biomea Fusion share’s latest price of $1.30 as on October 6, 2026 at 8:46 am IST, you will get 7.6923 shares of Biomea Fusion. Learn more about fractional shares .

What are the returns that Biomea Fusion has given to Indian investors in the last 5 years?

Biomea Fusion stock has given -89.7% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?